Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer

Abstract Sarcopenia affects the swallowing and chewing muscles, such as the masseter muscle. However, the significance of masseter muscle loss in pneumonia remains unclear. We investigated the effects of masseter muscle sarcopenia (MMS) on postoperative pneumonia in patients with esophageal cancer....

Full description

Bibliographic Details
Main Authors: Teppei Kamada, Hironori Ohdaira, Eisaku Ito, Junji Takahashi, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Masashi Yoshida, Ken Eto, Yutaka Suzuki
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20967-1
_version_ 1818024744533884928
author Teppei Kamada
Hironori Ohdaira
Eisaku Ito
Junji Takahashi
Keigo Nakashima
Yuichi Nakaseko
Norihiko Suzuki
Masashi Yoshida
Ken Eto
Yutaka Suzuki
author_facet Teppei Kamada
Hironori Ohdaira
Eisaku Ito
Junji Takahashi
Keigo Nakashima
Yuichi Nakaseko
Norihiko Suzuki
Masashi Yoshida
Ken Eto
Yutaka Suzuki
author_sort Teppei Kamada
collection DOAJ
description Abstract Sarcopenia affects the swallowing and chewing muscles, such as the masseter muscle. However, the significance of masseter muscle loss in pneumonia remains unclear. We investigated the effects of masseter muscle sarcopenia (MMS) on postoperative pneumonia in patients with esophageal cancer. In this retrospective cohort study, we analyzed the data of 86 patients who underwent esophagectomy for stage I–III esophageal cancer at our hospital between March 2013 and October 2021. The primary endpoint was postoperative pneumonia within 3 months of surgery. MMS was defined as a (1) masseter muscle index (MMI) that was less than the sex-specific MMI cutoff values, and (2) sarcopenia diagnosed using the L3-psoas muscle index (L3-PMI). Postoperative pneumonia was noted in 27 (31.3%) patients. In multivariate analysis, FEV1.0 < 1.5 L (odds ratio, OR: 10.3; 95% confidence interval, CI 1.56–67.4; p = 0.015), RLNP (OR: 5.14; 95%CI 1.47–17.9; p = 0.010), and MMS (OR: 4.83; 95%CI 1.48–15.8; p = 0.009) were independent risk factors for postoperative pneumonia. The overall survival was significantly worse in patients with pneumonia (log-rank: p = 0.01) than in those without pneumonia. Preoperative MMS may serve as a predictor of postoperative pneumonia in patients with esophageal cancer.
first_indexed 2024-12-10T04:05:05Z
format Article
id doaj.art-81e7de00d2544c12985d82f404448ec0
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-10T04:05:05Z
publishDate 2022-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-81e7de00d2544c12985d82f404448ec02022-12-22T02:02:52ZengNature PortfolioScientific Reports2045-23222022-09-011211810.1038/s41598-022-20967-1Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancerTeppei Kamada0Hironori Ohdaira1Eisaku Ito2Junji Takahashi3Keigo Nakashima4Yuichi Nakaseko5Norihiko Suzuki6Masashi Yoshida7Ken Eto8Yutaka Suzuki9Department of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, International University of Health and Welfare HospitalDepartment of Surgery, The Jikei University School of MedicineDepartment of Surgery, International University of Health and Welfare HospitalAbstract Sarcopenia affects the swallowing and chewing muscles, such as the masseter muscle. However, the significance of masseter muscle loss in pneumonia remains unclear. We investigated the effects of masseter muscle sarcopenia (MMS) on postoperative pneumonia in patients with esophageal cancer. In this retrospective cohort study, we analyzed the data of 86 patients who underwent esophagectomy for stage I–III esophageal cancer at our hospital between March 2013 and October 2021. The primary endpoint was postoperative pneumonia within 3 months of surgery. MMS was defined as a (1) masseter muscle index (MMI) that was less than the sex-specific MMI cutoff values, and (2) sarcopenia diagnosed using the L3-psoas muscle index (L3-PMI). Postoperative pneumonia was noted in 27 (31.3%) patients. In multivariate analysis, FEV1.0 < 1.5 L (odds ratio, OR: 10.3; 95% confidence interval, CI 1.56–67.4; p = 0.015), RLNP (OR: 5.14; 95%CI 1.47–17.9; p = 0.010), and MMS (OR: 4.83; 95%CI 1.48–15.8; p = 0.009) were independent risk factors for postoperative pneumonia. The overall survival was significantly worse in patients with pneumonia (log-rank: p = 0.01) than in those without pneumonia. Preoperative MMS may serve as a predictor of postoperative pneumonia in patients with esophageal cancer.https://doi.org/10.1038/s41598-022-20967-1
spellingShingle Teppei Kamada
Hironori Ohdaira
Eisaku Ito
Junji Takahashi
Keigo Nakashima
Yuichi Nakaseko
Norihiko Suzuki
Masashi Yoshida
Ken Eto
Yutaka Suzuki
Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
Scientific Reports
title Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
title_full Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
title_fullStr Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
title_full_unstemmed Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
title_short Association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
title_sort association between masseter muscle sarcopenia and postoperative pneumonia in patients with esophageal cancer
url https://doi.org/10.1038/s41598-022-20967-1
work_keys_str_mv AT teppeikamada associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT hironoriohdaira associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT eisakuito associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT junjitakahashi associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT keigonakashima associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT yuichinakaseko associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT norihikosuzuki associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT masashiyoshida associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT keneto associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer
AT yutakasuzuki associationbetweenmassetermusclesarcopeniaandpostoperativepneumoniainpatientswithesophagealcancer